The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
CYP3A4 phenotyping with midazolam to predict sunitinib exposure.
Nielka P van Erp
No relevant relationships to disclose
Djoeke de Wit
No relevant relationships to disclose
Alex Sparreboom
No relevant relationships to disclose
Jan den Hartigh
No relevant relationships to disclose
Margret den Hollander
No relevant relationships to disclose
Jacqueline M.C. Konig-Quartel
No relevant relationships to disclose
Trees Hessing
No relevant relationships to disclose
Henk-jan Guchelaar
No relevant relationships to disclose
Hans Gelderblom
No relevant relationships to disclose